GUGGENHEIM CAPITAL LLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 243 filers reported holding TG THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$656,695
-45.1%
78,552
+63.0%
0.01%
-33.3%
Q2 2023$1,196,866
+14.4%
48,183
-30.8%
0.01%0.0%
Q1 2023$1,046,573
-1.4%
69,586
-37.7%
0.01%
+50.0%
Q1 2022$1,061,000
-36.2%
111,655
+27.5%
0.01%
-33.3%
Q4 2021$1,664,000
-22.2%
87,579
+36.3%
0.01%
-30.8%
Q3 2021$2,138,000
-4.3%
64,243
+11.5%
0.01%0.0%
Q2 2021$2,235,000
-10.9%
57,620
+10.7%
0.01%
-18.8%
Q1 2021$2,508,000
+135.7%
52,036
-30.6%
0.02%
+433.3%
Q1 2018$1,064,000
-14.2%
74,974
-50.5%
0.00%0.0%
Q4 2017$1,240,000
+2.7%
151,387
+48.5%
0.00%0.0%
Q3 2017$1,207,000
+18.2%
101,935
+0.2%
0.00%0.0%
Q2 2017$1,021,000
-21.7%
101,723
-9.1%
0.00%
-25.0%
Q1 2017$1,304,000
+4.7%
111,923
-58.2%
0.00%0.0%
Q4 2016$1,246,000
+0.6%
267,985
+67.6%
0.00%0.0%
Q3 2016$1,238,000
+24.4%
159,879
-2.6%
0.00%
+33.3%
Q2 2016$995,000
-2.7%
164,213
+36.8%
0.00%0.0%
Q1 2016$1,023,000
-25.4%
120,021
+4.4%
0.00%
-25.0%
Q4 2015$1,372,000
+15.0%
114,924
-2.9%
0.00%0.0%
Q3 2015$1,193,000118,3540.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
RA Capital Management 2,813,779$33,568,0003.32%
Opaleye Management Inc. 300,000$3,579,0001.50%
BRIDGER MANAGEMENT, LLC 3,068,315$36,605,0001.21%
SECTORAL ASSET MANAGEMENT INC 1,521,667$18,153,0000.77%
STONERIDGE INVESTMENT PARTNERS LLC 332,576$3,968,0000.53%
Eventide Asset Management 537,600$6,414,0000.32%
Baker Brothers Advisors 2,003,991$23,908,0000.20%
Quantitative Systematic Strategies LLC 25,270$302,0000.08%
Candriam S.C.A. 236,200$2,818,0000.08%
COLUMBUS CIRCLE INVESTORS 705,389$8,415,0000.07%
View complete list of TG THERAPEUTICS INC shareholders